MedPath
HSA Product

PENGESIC CAPSULE 50 mg

Product approved by Health Sciences Authority (SG)

Basic Information

PENGESIC CAPSULE 50 mg

CAPSULE

Regulatory Information

SIN10512P

December 8, 1998

Prescription Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XN02AX02

Company Information

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

TRAMADOL HCl

Strength: 50.00 mg

Detailed Information

Contraindications

**CONTRAINDICATIONS** It is generally contraindicated in the following conditions: - Respiratory depression, especially in the presence of cyanosis and excessive bronchial secretion. - In the presence of acute alcoholism, head injuries and conditions in which intracranial pressure is raised. - It should not be used in patients receiving MAO inhibitors. - Previous hypersensitivity to Pengesic.

Indication Information

**INDICATIONS** In the treatment of moderate to severe acute or chronic pain and in painful diagnostic or therapeutic measures.

© Copyright 2025. All Rights Reserved by MedPath